Recent advances in the management of pulmonary arterial hypertension: lessons from the upfront combination of ambrisentan and tadalafil-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in the management of pulmonary arterial hypertension: lessons from the upfront combination of ambrisentan and tadalafil

Published:2021-02-23 Issue:4 Volume:15 Page:493-504
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Escribano Subías Pilar¹²,Aurtenetxe Pérez Agueda¹³,Pérez Olivares Carmen²⁴,Gómez Climent Leticia⁵,Diago Cabezudo Jesús I.⁵,Perelló Maria Francesca⁵

Affiliation:

1. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain

2. Unidad Multidisciplinar de Hipertensión Pulmonar, Servicio de Cardiología, Hospital Universitario 12 de Octubre, Madrid, Spain

3. Servicio de Neumología, Hospital Universitario Basurto, Bilbao, Spain

4. Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12), Madrid, Spain

5. Medical Department, GSK, Madrid, Spain

Funder

funded

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2021.1878027

Reference79 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2. A global view of pulmonary hypertension

3. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

4. Pulmonary Arterial Hypertension

5. Pulmonary Arterial Hypertension in France

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension;International Journal of Molecular Sciences;2023-02-19

2. Novel Chemicals Derived from Tadalafil Exhibit PRMT5 Inhibition and Promising Activities against Breast Cancer;International Journal of Molecular Sciences;2022-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3